Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleGLOBAL PIVOTAL PHASE 2 TRIAL OF THE CD19-TARGETED THERAPY CTL019 IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)-AN INTERIM ANALYSIS.AuthorsSchuster, S.J.; Bishop, M.R.; Tam, C.; Waller, E.K.; Borchmann, P.; Mcguirk, J.; Jäger, U.; Jaglowski, S.; Andreadis, C.; Westin, J.; Fleury, I.; Bachanova, V.; Foley, S.R.; Ho, P.J.; Mielke, S.; Holte, H.; Anak, O.; Pacaud, L.; Awasthi, R.; Tai, F.PublicationHematological Oncology, 2017, Vol 35, p27ISSN0278-0232Publication typeArticleDOI10.1002/hon.2437_6